Cordio Medical’s HearO app analyzes the voice of heart failure patients to monitor their condition. [Photo courtesy of Cordio Medical]
AstraZeneca and the Bellvitge University Hospital plan to launch the first pilot program for the Cordio Medical HearO app.
The HearO smartphone app provides widespread access to medical-grade technology for patients with congestive heart failure (CHF). It enables the patient to monitor symptoms, manage treatment and improve quality of life.
Astrazeneca said the pilot program aims to assess the feasibility of using the app to monitor CHF patients. The monitoring takes place in both the hospital and at-home settings. It includes tracking HearO’s success rate of patient compliance and its ability to issue notices prior to heart failure events.
Get the full story at our sister site, Medical Design & Outsourcing.